News News Category: General NewsPress Releases Year: - Any -2018201720162015201420132012 Items per page 102550 Aug 14 2018 Sophiris Bio Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights Read Jun 25 2018 Sophiris Bio Reports Top-Line Interim Safety and Biopsy Findings For its Phase 2b Clinical Trial of Topsalysin in Localized Prostate Cancer Read May 14 2018 Sophiris Bio Reports First Quarter 2018 Financial Results and Key Corporate Highlights Read Mar 21 2018 Sophiris Bio Reports Fourth Quarter and Full Year 2017 Financial Results and Key Corporate Highlights Read Mar 15 2018 Sophiris Bio to Present at 17th Annual Needham Healthcare Conference Read Dec 27 2017 Sophiris Bio to Participate in the 10th Annual Biotech Showcase Conference Read Dec 11 2017 Sophiris Bio Announces Complete Enrollment in Phase 2b Topsalysin Study of Localized Prostate Cancer Read Nov 27 2017 Sophiris Bio to Participate in the 29th Annual Piper Jaffray Healthcare Conference Read Nov 09 2017 Sophiris Bio Reports Third Quarter Financial Results and Key Corporate Highlights Read Oct 02 2017 Sophiris Bio Provides Enrollment Update on Topsalysin Phase 2b Study in Localized Prostate Cancer Read Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
News Category: General NewsPress Releases Year: - Any -2018201720162015201420132012 Items per page 102550 Aug 14 2018 Sophiris Bio Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights Read Jun 25 2018 Sophiris Bio Reports Top-Line Interim Safety and Biopsy Findings For its Phase 2b Clinical Trial of Topsalysin in Localized Prostate Cancer Read May 14 2018 Sophiris Bio Reports First Quarter 2018 Financial Results and Key Corporate Highlights Read Mar 21 2018 Sophiris Bio Reports Fourth Quarter and Full Year 2017 Financial Results and Key Corporate Highlights Read Mar 15 2018 Sophiris Bio to Present at 17th Annual Needham Healthcare Conference Read Dec 27 2017 Sophiris Bio to Participate in the 10th Annual Biotech Showcase Conference Read Dec 11 2017 Sophiris Bio Announces Complete Enrollment in Phase 2b Topsalysin Study of Localized Prostate Cancer Read Nov 27 2017 Sophiris Bio to Participate in the 29th Annual Piper Jaffray Healthcare Conference Read Nov 09 2017 Sophiris Bio Reports Third Quarter Financial Results and Key Corporate Highlights Read Oct 02 2017 Sophiris Bio Provides Enrollment Update on Topsalysin Phase 2b Study in Localized Prostate Cancer Read Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last